Theraclion SA (EPA:ALTHE)

France flag France · Delayed Price · Currency is EUR
0.7800
+0.0300 (4.00%)
Sep 4, 2025, 1:32 PM CET
4.00%
Market Cap35.24M
Revenue (ttm)830.21K
Net Income (ttm)-5.76M
Shares Out46.98M
EPS (ttm)-0.12
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume65,725
Average Volume310,673
Open0.7220
Previous Close0.7500
Day's Range0.7220 - 0.7860
52-Week Range0.1416 - 0.9400
Beta-0.15
RSI56.46
Earnings DateOct 29, 2025

About Theraclion

Theraclion SA provides therapeutic ultrasound equipment. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment to protect the patient’s skin and optimize image quality. The company was incorporated in 2004 and is headquartered in Malakoff, France. [Read more]

Sector Healthcare
Founded 2004
Employees 32
Stock Exchange Euronext Paris
Ticker Symbol ALTHE
Full Company Profile

Financial Performance

In 2024, Theraclion's revenue was 830,209, a decrease of -54.44% compared to the previous year's 1.82 million. Losses were -5.76 million, 56.7% more than in 2023.

Financial Statements

News

There is no news available yet.